Advisors Asset Management Inc. lessened its stake in Cardinal Health, Inc. (NYSE:CAH - Free Report) by 27.2% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 39,219 shares of the company's stock after selling 14,648 shares during the period. Advisors Asset Management Inc.'s holdings in Cardinal Health were worth $4,638,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
A number of other large investors have also added to or reduced their stakes in CAH. Rothschild Investment LLC grew its position in shares of Cardinal Health by 10.1% in the 4th quarter. Rothschild Investment LLC now owns 858 shares of the company's stock worth $101,000 after buying an additional 79 shares during the last quarter. Private Trust Co. NA grew its holdings in Cardinal Health by 11.0% in the fourth quarter. Private Trust Co. NA now owns 930 shares of the company's stock worth $110,000 after purchasing an additional 92 shares during the last quarter. Checchi Capital Advisers LLC grew its holdings in Cardinal Health by 2.7% in the fourth quarter. Checchi Capital Advisers LLC now owns 3,479 shares of the company's stock worth $411,000 after purchasing an additional 93 shares during the last quarter. MWA Asset Management increased its position in shares of Cardinal Health by 2.9% during the fourth quarter. MWA Asset Management now owns 3,324 shares of the company's stock worth $393,000 after purchasing an additional 95 shares in the last quarter. Finally, Transcend Capital Advisors LLC lifted its holdings in shares of Cardinal Health by 3.6% during the 4th quarter. Transcend Capital Advisors LLC now owns 2,735 shares of the company's stock valued at $323,000 after purchasing an additional 96 shares during the last quarter. 87.17% of the stock is currently owned by institutional investors.
Wall Street Analysts Forecast Growth
Several research analysts recently issued reports on the company. Bank of America raised Cardinal Health from a "neutral" rating to a "buy" rating and upped their target price for the company from $132.00 to $145.00 in a research report on Monday, January 6th. TD Cowen upgraded shares of Cardinal Health from a "hold" rating to a "buy" rating and upped their price objective for the company from $130.00 to $144.00 in a report on Wednesday, January 8th. JPMorgan Chase & Co. lifted their target price on shares of Cardinal Health from $142.00 to $145.00 and gave the stock a "neutral" rating in a research note on Tuesday, February 4th. Argus set a $148.00 price target on shares of Cardinal Health in a research note on Tuesday, February 4th. Finally, Morgan Stanley raised their price target on shares of Cardinal Health from $136.00 to $142.00 and gave the stock an "overweight" rating in a report on Friday, January 31st. Four investment analysts have rated the stock with a hold rating and eleven have issued a buy rating to the company. According to data from MarketBeat.com, Cardinal Health has an average rating of "Moderate Buy" and an average price target of $139.36.
Check Out Our Latest Research Report on Cardinal Health
Cardinal Health Trading Up 1.0 %
CAH traded up $1.36 during midday trading on Monday, hitting $133.25. 2,153,232 shares of the company traded hands, compared to its average volume of 1,975,724. The business has a 50 day simple moving average of $127.35 and a two-hundred day simple moving average of $120.08. Cardinal Health, Inc. has a 52-week low of $93.17 and a 52-week high of $133.67. The company has a market capitalization of $32.19 billion, a price-to-earnings ratio of 24.86, a PEG ratio of 1.49 and a beta of 0.66.
Cardinal Health (NYSE:CAH - Get Free Report) last issued its quarterly earnings results on Thursday, January 30th. The company reported $1.93 earnings per share for the quarter, beating analysts' consensus estimates of $1.74 by $0.19. Cardinal Health had a net margin of 0.59% and a negative return on equity of 59.57%. Equities research analysts anticipate that Cardinal Health, Inc. will post 7.95 earnings per share for the current year.
Cardinal Health Dividend Announcement
The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, April 15th. Investors of record on Tuesday, April 1st will be paid a $0.5056 dividend. This represents a $2.02 annualized dividend and a yield of 1.52%. The ex-dividend date of this dividend is Tuesday, April 1st. Cardinal Health's dividend payout ratio is currently 37.69%.
Cardinal Health Profile
(
Free Report)
Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.
See Also

Before you consider Cardinal Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cardinal Health wasn't on the list.
While Cardinal Health currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.